|

ST-01156 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • SEED Therapeutics, Inc.1

Indications

  • Liver Disease1
  • Biliary Tract Cancer (BTC)1
  • Hepatocellular Carcinoma (HCC)1
  • Ewing Sarcoma1
  • Advanced Solid Tumors1

Duarte, California1 trial

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

The City of Hope National Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.